Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 6.25
  • 52 Week Low: 0.88
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 120,404
  • Market Cap: £142.99m
  • RiskGrade: 268

Latest ShareCast News

Allergy Therapeutics starts dosing peanut allergy vaccine candidate

By Josh White

Date: Monday 27 Mar 2023

(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.

AGY Regulatory News

Interim Results for six months ended 31 Dec 2023 27-Mar-2024 07:00 RNS
Update on funding 27-Mar-2024 07:00 RNS
VLP Peanut PROTECT Trial Update 12-Mar-2024 08:59 RNS
Appointment of Shaun Furlong to Board of Directors 11-Mar-2024 07:00 RNS
Result of AGM 08-Mar-2024 13:49 RNS

AGY News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 3.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 6.25
52 Week Low 0.88
Volume 120,404
Shares Issued 4,766.44m
Market Cap £142.99m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.99% below the market average17.99% below the market average17.99% below the market average17.99% below the market average17.99% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Price Trend
32.11% below the market average32.11% below the market average32.11% below the market average32.11% below the market average32.11% below the market average
1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average
Income Not Available
Growth
83.27% below the market average83.27% below the market average83.27% below the market average83.27% below the market average83.27% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average

AGY Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
15:40 62 @ 2.80p
15:40 997 @ 3.20p
15:40 497 @ 2.80p
15:40 497 @ 3.20p
15:40 78 @ 2.80p

AGY Key Personnel

CEO Manuel Llobet

Top of Page